Search

Your search keyword '"Pearce LA"' showing total 169 results

Search Constraints

Start Over You searched for: Author "Pearce LA" Remove constraint Author: "Pearce LA"
169 results on '"Pearce LA"'

Search Results

1. Advancing cross-sectoral data linkage to understand and address the health impacts of social exclusion: Challenges and potential solutions.

3. Frequency and patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial

4. Differences in Treatment of Supracondylar Humerus Fractures Requiring Transfer Between Facilities

5. Enzyme mediated incorporation of zirconium-89 or copper-64 into a fragment antibody for same day imaging of epidermal growth factor receptor

6. Challenging the Stereotypes: Unexpected Features of Sexual Exploitation among Homeless and Street-Involved Boys in Western Canada.

7. A rapid review of early guidance to prevent and control COVID-19 in custodial settings.

9. Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source NAVIGATE-ESUS Trial

10. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.

11. The Causal Effect of Opioid Agonist Treatment on Adherence to Direct-Acting Antiviral Treatment for Hepatitis C Virus

12. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.

13. Identifying mental health and substance use disorders using emergency department and hospital records: a population-based retrospective cohort study of diagnostic concordance and disease attribution.

14. Repair of a Radial Tear of the Meniscus Augmented With a Biocomposite Scaffold

19. Lessons from the Stroke Prevention in Atrial Fibrillation trials.

20. Establishing a community of practice of researchers, practitioners, policy-makers and communities to sustainably manage environmental health risks in Ecuador

21. Electrocardiographic Differentiation of Early Repolarization From Subtle Anterior ST-Segment Elevation Myocardial Infarction.

23. Adverse childhood experiences, morbidity, mortality and resilience in socially excluded populations: protocol for a systematic review and meta-analysis.

24. Advancing cross-sectoral data linkage to understand and address the health impacts of social exclusion: Challenges and potential solutions.

25. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.

26. Validation and endorsement of health system performance measures for opioid use disorder in British Columbia, Canada: A Delphi panel study.

27. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.

28. Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial.

29. Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale.

30. Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial.

31. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

33. A rapid review of early guidance to prevent and control COVID-19 in custodial settings.

34. Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.

35. Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials.

36. Challenging the Stereotypes: Unexpected Features of Sexual Exploitation among Homeless and Street-Involved Boys in Western Canada.

37. Enzyme mediated incorporation of zirconium-89 or copper-64 into a fragment antibody for same day imaging of epidermal growth factor receptor.

39. Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trial.

40. Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis.

41. Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada.

42. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.

43. Stratification Dynamics of Titan's Lakes via Methane Evaporation.

44. A giant planet candidate transiting a white dwarf.

45. Antithrombotic treatment in patients with stroke and supracardiac atherosclerosis.

46. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.

47. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source.

48. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.

49. Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial.

50. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.

Catalog

Books, media, physical & digital resources